In an assessment of data from the International Network on Cancer registry, researchers determined that maternal 5-year survival for pregnant women with HL was comparable to that of their nonpregnant counterparts.
Researchers compared models for determining cumulative exposure of busulfan in adult and pediatric patients receiving the drug prior to allo-HCT.
A substudy of the PACIFIC trial sought to determine if low-grade pneumonitis associated with durvalumab should deter its use in patients with NSCLC.
Using a subset from the GeparOcto trial, researchers sought to determine if IV FCM was superior to physicians’ choice in treating chemotherapy-induced anemia in patients with breast cancer.
Researchers investigated the efficacy and safety of CHOP-like therapy for treatment-naïve patients with simultaneous diagnoses of NHL and HIV-positive.
Interviews with young cancer survivors revealed the 3 themes that define their concerns regarding the end of treatment.
Results of a novel program in which nurses fully provided services related to TIVADs, replacing use of PICC lines and improving patient quality of life and satisfaction.
A single-institution study is able to reproduce results of previous studies on the use of a scalp cooling system to prevent chemotherapy-induced hair loss in patients with breast cancer receiving anthracycline and/or taxane-based therapies.
Researchers report on a study comparing the US cost and clinical benefit of recently approved cancer drugs with those in Europe.
Researchers present study findings that demonstrate the association between low-dose aspirin and risk for gastric or esophageal cancer at ESMO Congress 2019.
